🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/09/2014 | 114,10 | 114,23 | 111,85 | 112,38 | -1,07% | 2,09% | 546.700 |
| 03/09/2014 | 115,51 | 115,70 | 112,05 | 113,60 | -1,41% | 3,16% | 1.229.000 |
| 02/09/2014 | 115,74 | 119,06 | 113,13 | 115,22 | -2,22% | 5,12% | 1.595.700 |
| 29/08/2014 | 90,40 | 118,76 | 90,40 | 117,83 | +28,51% | 31,37% | 6.442.600 |
| 28/08/2014 | 92,89 | 93,51 | 91,42 | 91,69 | -1,26% | 2,25% | 487.600 |
| 27/08/2014 | 94,68 | 94,94 | 92,26 | 92,86 | -1,75% | 2,83% | 634.600 |
| 26/08/2014 | 95,19 | 95,55 | 93,62 | 94,51 | -0,27% | 2,03% | 408.400 |
| 25/08/2014 | 94,55 | 96,20 | 93,97 | 94,77 | +0,68% | 2,36% | 344.500 |
| 22/08/2014 | 93,98 | 94,69 | 93,16 | 94,13 | +0,41% | 1,63% | 362.900 |
| 21/08/2014 | 93,56 | 93,94 | 92,49 | 93,75 | +0,51% | 1,55% | 461.200 |
| 20/08/2014 | 93,33 | 93,57 | 92,60 | 93,27 | -0,04% | 1,04% | 440.400 |
| 19/08/2014 | 93,00 | 94,01 | 92,68 | 93,31 | +0,54% | 1,43% | 476.900 |
| 18/08/2014 | 92,74 | 93,33 | 91,92 | 92,81 | +1,11% | 1,52% | 446.500 |
| 15/08/2014 | 90,08 | 91,99 | 89,85 | 91,79 | +2,26% | 2,38% | 571.300 |
| 14/08/2014 | 88,26 | 89,84 | 87,64 | 89,76 | +2,12% | 2,49% | 350.000 |
| 13/08/2014 | 88,68 | 89,18 | 86,82 | 87,90 | -0,68% | 2,66% | 456.600 |
| 12/08/2014 | 87,39 | 88,59 | 86,77 | 88,50 | +1,26% | 2,08% | 481.500 |
| 11/08/2014 | 89,62 | 89,62 | 87,12 | 87,40 | -1,51% | 2,79% | 492.500 |
| 08/08/2014 | 86,18 | 89,06 | 86,05 | 88,74 | +2,66% | 3,49% | 401.100 |
| 07/08/2014 | 88,55 | 89,24 | 86,04 | 86,44 | -2,49% | 3,61% | 561.000 |
| 06/08/2014 | 89,76 | 90,84 | 88,06 | 88,65 | -1,62% | 3,10% | 588.100 |
| 05/08/2014 | 89,44 | 90,80 | 89,08 | 90,11 | +0,12% | 1,92% | 459.600 |
| 04/08/2014 | 89,78 | 90,79 | 88,70 | 90,00 | +0,55% | 2,33% | 625.900 |
| 01/08/2014 | 90,64 | 90,93 | 88,51 | 89,51 | -1,57% | 2,67% | 710.100 |
| 31/07/2014 | 92,72 | 93,24 | 89,36 | 90,94 | -2,52% | 4,18% | 733.700 |
| 30/07/2014 | 99,47 | 101,82 | 92,83 | 93,29 | -5,01% | 9,04% | 1.230.400 |
| 29/07/2014 | 95,00 | 102,27 | 94,00 | 98,21 | +8,10% | 8,71% | 1.665.000 |
| 28/07/2014 | 92,00 | 92,03 | 89,92 | 90,85 | -0,81% | 2,29% | 325.900 |
| 25/07/2014 | 91,77 | 92,22 | 90,42 | 91,59 | -0,80% | 1,96% | 381.500 |
| 24/07/2014 | 93,78 | 94,67 | 92,15 | 92,33 | -1,55% | 2,69% | 412.600 |